MyCondro™
MyCondro™ is a fermentation-derived form of chondroitin sulfate, an ingredient linked with superior joint health. Chondroitin sulfate has become widely used as a dietary supplement to help keep joints healthy and promote healthy cartilage.
Chondroitin sulfate has been traditionally sourced from animals, but concerns over cross-contamination and manufacturing processes, as driven demand for a non-animal source of this key nutrient. Gnosis by Lesaffre is proud to fulfill this demand with its revolutionary ingredient MyCondro™.

- Product category
Active ingredients
- Market segments
-
Mobility & Joint
Digestion & Gut
- Health benefits
-
Joint
Sports Nutrition
Digestive Comfort
- Allergens and
certificates Gluten-free
Lactose-free
Non GMO
Vegetarian and Vegan
- Download
- Download The Brochure
MyCondro™ is totally safe, pure, and highly bioavailable
We can guarantee the high quality and purity profile of MyCondro™ due to our controlled, reliable, and replicable fermentation process. MyCondro™ is free from prions and animal viruses thanks to its fermentation-derived origin. MyCondro™ is also not unadulterated, unlike a process that often occurs intentionally in animal chondroitin. All these features make MyCondro™ pure and free from allergens and GMOs.

Supplementation your joints deserve!
MyCondro™ is an excellent solution for reducing the risk of moderate knee osteoarthritis and joint degeneration. Indeed, chondroitin is a component of joints naturally produced by the human body. Additional benefits include pain relief, anti-inflammatory activity, and increased articular function. The efficacy of MyCondro™ has been validated through clinical trials.


A revolutionary fermentation-derived chondroitin sulfate
MyCondro™ is the world’s first chondroitin sulfate produced through fermentation, making it a unique market offering. Patents protect the innovative production process of MyCondro™. This non-animal chondroitin sulfate also has patents based on scientific advances in bioavailability. The ingredient is also compliant with the USP monograph of chondroitin sulfate sodium.
Enhancing bioavailability by 45%
A clinical trial highlights the superior bioavailability of MyCondro™ over cattle-derived chondroitin sulfate. Thanks to the higher bioavailability of MyCondro™, a lower dose, 600mg, is needed to support joint health effectively compared to animal chondroitin. Even five hours after administration, the plasmatic concentration of MyCondro™ remained 89% higher than that of the animal-derived option.

Related products
Tt enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Titre thématique
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Et, egestas tempus tellus etiam sed. Quam a scelerisque amet ullamcorper eu enim et fermentum, augue. Aliquet amet volutpat quisque ut interdum tincidunt duis.
Frequently asked questions
Can’t find what you are looking for?
Latest news & events

- Mobility & Joint
- MyCondro®
- News
- Jun 05, 2025
Redefining Joint Health: Gnosis by Lesaffre Showcases MyCondro™ at CMA Innovation Day
At the recent Innovation Day seminar hosted by Complementary Medicines Australia (CMA), Gnosis by...

- MenaQ7®
- Mobility & Joint
- News
- Jun 02, 2025
Supplementation with Menaquinone-7 (as MenaQ7®) Slows the Progression of Coronary Artery Calcification
The first results from the VitaK-CAC Trial, “Menaquinone-7 Slows Down Progression of Coronary Artery...

- MenaQ7®
- Mobility & Joint
- News
- May 21, 2025
K2SAC’s 4th Meeting Showcases New Clinical Insights and Emerging Talent in Vitamin K2 Research
On May 12-13, the 4th Gnosis Vitamin K2 Scientific Advisory Committee meeting convened leading...